About the Alkermes Inspiration Grants® Program

Organizations supporting people living with addiction, serious mental illness and cancer have faced unique needs and challenges during the COVID pandemic. The 2020 Alkermes Inspiration Grants identified nonprofit groups meeting the unique needs of patients we serve and provided support to their efforts. To learn more about the impact of these grants, check out our new video.

About AlkermesAlkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com